Osteoporosis drug may find second use
Researchers say a popular osteoporosis drug may help breast cancer patients avoid bone fractures.
Experts looked at early-stage breast cancer patients who were receiving a drug that can damage bones.
Half were given the osteoporosis drug Zometa or Reclast.
Researchers found those given the drug experienced a bone density boost, while those not on the drug had bone loss.
